NEWARK, Del.--(BUSINESS WIRE)--Strategic Diagnostics Inc. (Nasdaq:SDIX) - a biotechnology company and a leading provider of antibody products and analytical test kits for a broad range of food, water, agricultural, industrial, environmental and scientific applications, today reported financial results for the quarter ended March 31, 2007. Revenues for the quarter increased 6% to $6.6 million, compared to $6.3 million for the same period in 2006. Revenues in the first quarter of 2007 were positively impacted by a 32% increase in sales of antibody products. Sales of food pathogen products grew 8% globally and 16.0% in the United States.
